showed a trendp =0.05
The levodopa-equivalent daily dosage showed a trend towards a negatively moderating effect on antisaccade error rate with a statistical significance at the cut-off value ( p =0.05).
The levodopa-equivalent daily dosage showed a trend towards a negatively moderating effect on antisaccade error rate with a statistical significance at the cut-off value ( p =0.05).
However, this assumption remains speculative, since the analysis of the levodopa-equivalent daily dosage as a moderator of antisaccade error rate did not reach statistical significance.